McKesson Corporation (LON:0JZU)
853.37
+4.43 (0.52%)
At close: Nov 7, 2025
McKesson Revenue
McKesson had revenue of $103.15B USD in the quarter ending September 30, 2025, with 10.14% growth. This brings the company's revenue in the last twelve months to $387.09B, up 17.23% year-over-year. In the fiscal year ending March 31, 2025, McKesson had annual revenue of $359.05B with 16.22% growth.
Revenue (ttm)
$387.09B
Revenue Growth
+17.23%
P/S Ratio
0.28
Revenue / Employee
$8.60M
Employees
45,000
Market Cap
79.87B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 359.05B | 50.10B | 16.22% |
| Mar 31, 2024 | 308.95B | 32.24B | 11.65% |
| Mar 31, 2023 | 276.71B | 12.75B | 4.83% |
| Mar 31, 2022 | 263.97B | 25.74B | 10.80% |
| Mar 31, 2021 | 238.23B | 7.18B | 3.11% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
McKesson News
- 2 days ago - MCK Crosses Above Average Analyst Target - Nasdaq
- 2 days ago - Decoding McKesson Corp (MCK): A Strategic SWOT Insight - GuruFocus
- 2 days ago - UBS Raises McKesson (MCK) Price Target to $980, Maintains Buy Rating | MCK Stock News - GuruFocus
- 2 days ago - McKesson (MCK) Analyst Rating Update by Baird: Price Target Raised | MCK Stock News - GuruFocus
- 2 days ago - MCK: Morgan Stanley Raises McKesson Price Target to $916, Maintains Overweight Rating | MCK ... - GuruFocus
- 2 days ago - McKesson (MCK) Q2 2026 Earnings Call Transcript - The Motley Fool
- 3 days ago - MCK Q2 Earnings Beat, Sales Miss, '26 EPS View Up, Stock Down - Nasdaq
- 3 days ago - McKesson Corp (MCK) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Raised Earnings ... - GuruFocus